Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis

Area of Science:

• Urology
• Hematology
• Pediatric Oncology

Background:

• Severe hemorrhagic cystitis is a debilitating complication following bone marrow transplantation.
• Viral etiologies contribute significantly to persistent hemorrhagic cystitis.
• Previous treatments involving bladder manipulations have shown limited efficacy, especially in viral cases.

Purpose of the Study:

• To evaluate the efficacy of intravesical prostaglandin E1 instillations in treating severe hemorrhagic cystitis in pediatric patients post-marrow transplantation.
• To assess the safety and effectiveness of this novel therapeutic approach.

Main Methods:

• Six pediatric patients with severe hemorrhagic cystitis post-marrow transplantation were treated.
• All patients received direct intravesical instillations of prostaglandin E1.
• Clinical outcomes, specifically resolution of hematuria, were monitored.

Main Results:

• Five out of six patients (83%) experienced complete resolution of hematuria following prostaglandin E1 instillation.
• The treatment was well-tolerated, with no reported toxicity.
• This contrasts with previous experiences where viral-induced hemorrhagic cystitis was refractory to other interventions.

Conclusions:

• Intravesical prostaglandin E1 is a promising, non-toxic treatment for severe hemorrhagic cystitis in pediatric bone marrow transplant recipients.
• Further research is warranted to elucidate the mechanism of action of prostaglandin E1 on bladder epithelium.
• This approach offers a potential alternative for managing refractory cases, including those with viral etiology.